title: Hepatotoxicity induced by diethylnitrosamine causes no significant disturbances of systemic glucose homeostasis in rats.
abstract: In rats, a moderately hepatotoxic single dose of diethylnitrosamine (DEN) 100 mg/kg causing depletion of liver glycogen, elevation of aspartate aminotransferase and decreased liver uptake of 3-O-methylglucose, resulted in substantial changes in insulin and glucagon balance. Two days after DEN, insulin binding to liver membranes and insulin removal by the liver were sharply reduced whereas its binding to muscle and adipocyte membranes remained unaltered. Serum insulin (random and after an overnight fast) remained normal. Intravenous (I.V.) insulin (10 U/kg) caused the usual degree of hypoglycemia that, however, lasted longer than in the control animals. Removal of glucagon by liver was also depressed in spite of its normal binding to hepatocytes, and peripheral serum glucagon was increased three-fold. I.V. glucagon (40 micrograms/kg) resulted in a blunted response of plasma glucose. I.V. glucose tolerance test (1 g/kg) remained normal in spite of the insulin increase to a level twice as high as in the controls, and in spite of nonsuppressed glucagon. These changes were still present after 1-3 months, but disappeared by 6 months. The results demonstrate remarkable ability of homeostatic mechanisms to preserve normal plasma glucose and glucose tolerance in spite of dramatic changes in insulin and glucagon.
authors.affiliation: Department of Diabetes, Endocrinology and Metabolism, City of Hope National Medical Center, Duarte, California.
authors.forename: D L
authors.initials: DL
authors.lastname: Hwang
authors.forename: A
authors.initials: A
authors.lastname: Lev-Ran
authors.forename: Y C
authors.initials: YC
authors.lastname: Tay
authors.forename: P
authors.initials: P
authors.lastname: De Meyts
mesh_terms: D000818:Animals; D001219:Aspartate Aminotransferases / Q000378:metabolism; D001786:Blood Glucose / Q000187:drug effects; D056486:Chemical and Drug Induced Liver Injury; D004052:Diethylnitrosamine / Q000008:administration & dosage; D005934:Glucagon / Q000097:blood / Q000378:metabolism*; D006706:Homeostasis / Q000187:drug effects; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D007700:Kinetics; D008099:Liver / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D008107:Liver Diseases / Q000378:metabolism; D008297:Male; D051381:Rats; D011916:Rats, Inbred F344; D011972:Receptor, Insulin / Q000097:blood / Q000378:metabolism; D011964:Receptors, Gastrointestinal Hormone / Q000097:blood / Q000378:metabolism; D018027:Receptors, Glucagon
chemical_list: D001786:Blood Glucose; D007328:Insulin; D011964:Receptors, Gastrointestinal Hormone; D018027:Receptors, Glucagon; D004052:Diethylnitrosamine; D005934:Glucagon; D001219:Aspartate Aminotransferases; D011972:Receptor, Insulin